ATTO
Atento SA
NASDAQ · Healthcare · Biotechnology · US
$13.89
+1.17%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 469.70x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.62x
- Price / sales
- 469.70x
- Price / cash flow
- -10.71x
Enterprise value
- Enterprise value
- $781.5M
- EV / sales
- 578.90x
- EV / EBITDA
- -11.78x
- EV / EBIT
- -11.64x
- Market cap
- $634.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026